Must-read news from the week of June 13

This week’s top articles:

FDA authorizes Moderna, Pfizer-BioNTech COVID-19 vaccines for children down to 6 months of age

The FDA today announces the EUA of both Moderna and Pfizer-BioNTech COVID-19 vaccines for use in children aged 6 months and older.

Over 300 pediatricians submit personal gun violence testimonies to Congressional record

Ahead of the US Senate Judiciary Committee hearing on gun violence prevention, the American Academy of Pediatrics announced the submission of a statement including more than 300 pediatricians sharing their personal testimonies on the subject.

Once-weekly somapacitan injection shows efficacy in children with GHD

Data from a recent study of once weekly somapacitan injection shows positive results for prepubertal children with growth hormone deficiency (GHD).

FDA accepts sNDA for review of Myfembree in uterine fibroid treatment

The FDA recently announced the acceptance of a supplemental New Drug Application for relugolix 40 mg, estradiol 1 mg, and norethindrone acetate .5 mg in the treatment of heavy menstrual bleeding associated with uterine fibroids in premenopausal women.

More articles from this week:

The challenges of prescribing isotretinoin

Scynexis submits sNDA for expanded indication of ibrexafungerp tablets

Comparing recruitment modalities for parents of children with autism

The youth mental health crisis: supporting patients with ASD and ADHD

Prolonged stress and anxiety during pregnancy disruptive to fetal brain development

An inside look on the dupilumab approval

Atopic dermatitis and infertility

AMA: Climate change is a public health crisis

FDA committee recommends Pfizer-BioNTech, Moderna COVID-19 vaccines for kids 6 months and older

Reckitt Mead Johnson receives FDA approval to import 66 million formula servings

AMA looks to fight back against health professionals spreading misinformation

An Update on the Presentation, Nosology, and Causes of Postpartum Psychosis

Having "the talk" with teen patients